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In original article, there are few facts published
incorrectly. The correct Table 4 is given below.
There are few corrections in the second
paragraph under the Table 4.
‘‘In the additional scenario considering sev-
ere and non-severe hypoglycaemic episodes, the
total annual cost reached €2,951,884 and
€2,309,089 for the cohort with SMBG and the
FreeStyle Libre 2 system, respectively.’’
‘‘Cost savings with the use of the FreeStyle
Libre 2 system as compared to SMBG would be
up to €642,795 per year (- 21.8%) (Table 4).’’
The original article has been updated.
The original article can be found online at https://doi.
org/10.1007/s13300-021-01064-4.
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F. Gómez-Peralta
Unidad de Endocrinologı́a y Nutrición, Hospital
General de Segovia, Segovia, Spain
S. Artola
Centro de Salud José Marvá, Madrid, Spain
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Table 4 Results of the sensitivity analyses




Absolute difference FreeStyle Libre 2
system vs SMBG (percentage variation)
Base case for T2DM with basal-bolus insulin €2,700,499 €2,119,546 € - 580,953 (- 21.5%)
SA1 (1.3 severe hypoglycaemic episodes/patient-
year) [37]
€1,793,470 €1,655,147 € - 138,323 (- 7.7%)
SA2 (3 strips & lancets a day for SMBG) €2,295,071 €2,119,546 € - 175,525 (- 7.6%)
SA3 (0.66 strips & lancets a day for FreeStyle
Libre 2 users) [38]
€2,700,499 €2,181,712 € - 518,787 (- 19.2%)
SA4 (3 strips & lancets a day for SMBG, and 0.66
for FreeStyle Libre 2 users)
€2,295,071 €2,181,712 € - 113,360 (-4.9%)
SA5 (13 strips & lancets a day for SBMG,
equivalent to daily scans in real-world studies)
[38]
€3,646,496 €2,119,546 € - 1,526,950 (- 41.9%)
SA6 (including severe and non-severe
hypoglycaemic episodes)
€2,951,884 €2,309,089 € - 642,795 (- 21.8%)
SA sensitivity analysis, SMBG self-monitoring of capillary blood glucose, T2DM type 2 diabetes mellitus
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